Commerzbank Aktiengesellschaft’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,110	Closed	-$443K	–	841
2019 Q2	$443K	Buy	6,110 +3,816	+166%	+$293K	﹤0.01%	768
2019 Q1	$214K	Sell	2,294 -2,902	-56%	-$243K	﹤0.01%	785
2018 Q4	$379K	Buy	5,196 +2,511	+94%	+$193K	﹤0.01%	721
2018 Q3	$235K	Buy	2,685 +249	+10%	+$25K	﹤0.01%	845
2018 Q2	$240K	Buy	+2,436	New	+$242K	﹤0.01%	812
2016 Q4	–	Sell	-3,262	Closed	-$221K	–	974
2016 Q3	$221K	Sell	3,262 -1,095	-25%	-$77.3K	﹤0.01%	816
2016 Q2	$242	Sell	4,357 -605	-12%	-$38.1K	﹤0.01%	886
2016 Q1	$311K	Sell	4,962 -466	-9%	-$31K	﹤0.01%	857
2015 Q4	$511K	Buy	5,428 +163	+3%	+$15.1K	﹤0.01%	862
2015 Q3	$423K	Sell	5,265 -497	-9%	-$55.2K	﹤0.01%	839
2015 Q2	$691K	Buy	5,762 +3,449	+149%	+$412K	﹤0.01%	909
2015 Q1	$242K	Sell	2,313 -1,073	-32%	-$109K	﹤0.01%	1059
2014 Q4	$328K	Buy	+3,386	New	+$314K	﹤0.01%	1066